Literature DB >> 20080294

Importance of additional "extreme" anterior apical needle biopsies in the initial detection of prostate cancer.

Ayman S Moussa1, Alaa Meshref, Lynn Schoenfield, Amr Masoud, Sherif Abdel-Rahman, Jianbo Li, Sara Flazoura, Cristina Magi-Galluzzi, Amr Fergany, Khaled Fareed, J Stephen Jones.   

Abstract

OBJECTIVES: To describe our experience of adding extreme apical cores in men undergoing initial biopsy. Prostate cancer detection efforts have focused on increasing the number of cores. A more significant factor, however, may be their location. Laterally directed and apical cores have been associated with the highest cancer detection rate, especially the apical cores for men undergoing repeated biopsies.
METHODS: A prospective trial was conducted between September 2007 and April 2009. A total of 181 men with increased prostate-specific antigen (PSA) or abnormal digital rectal examination (DRE), or both, underwent an initial transrectal ultrasound-guided biopsy (TRUS-BX). All patients underwent a standard 12-core biopsy scheme plus 2 additional cores taken from the extreme anterior apex, defined as the site immediately lateral to the junction of apex and urethra. Each core was marked by a special colored ink for identification. Site-specific detection and tumor characteristics were reported.
RESULTS: Prostate cancer was detected in 86 patients (47.5%). The apical cores (3 on each side) achieved the highest cancer detection rate (73.6% of all cancers), and the additional extreme anterior apical cores (1 on each side) achieved the highest rate of unique cancer detection (P = .011).
CONCLUSIONS: From our experience, the apical cores, especially the extreme apical cores, increase prostate cancer detection on initial TRUS-BX and minimize the potential for misdiagnosis and need for repeat biopsy. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20080294     DOI: 10.1016/j.urology.2009.11.008

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  25 in total

1.  Incremental value of transition zone and midline apical biopsy at baseline TRUS-guided biopsy for prostate cancer detection.

Authors:  D M Somford; W Vreuls; T S Jansen; J P van Basten; H Vergunst
Journal:  World J Urol       Date:  2013-07-20       Impact factor: 4.226

2.  MRI-directed cognitive fusion-guided biopsy of the anterior prostate tumors.

Authors:  Ian G Murphy; Elaine NiMhurchu; Robert G Gibney; Colm J McMahon
Journal:  Diagn Interv Radiol       Date:  2017 Mar-Apr       Impact factor: 2.630

3.  Hyperpolarized MRI of Human Prostate Cancer Reveals Increased Lactate with Tumor Grade Driven by Monocarboxylate Transporter 1.

Authors:  Kristin L Granlund; Sui-Seng Tee; Hebert A Vargas; Serge K Lyashchenko; Ed Reznik; Samson Fine; Vincent Laudone; James A Eastham; Karim A Touijer; Victor E Reuter; Mithat Gonen; Ramon E Sosa; Duane Nicholson; YanWei W Guo; Albert P Chen; James Tropp; Fraser Robb; Hedvig Hricak; Kayvan R Keshari
Journal:  Cell Metab       Date:  2019-09-26       Impact factor: 27.287

Review 4.  Management of rising prostate-specific antigen after a negative biopsy.

Authors:  David A Levy; J Stephen Jones
Journal:  Curr Urol Rep       Date:  2011-06       Impact factor: 3.092

Review 5.  Multiparametric magnetic resonance imaging: Overview of the technique, clinical applications in prostate biopsy and future directions.

Authors:  Hüseyin Cihan Demirel; John Warren Davis
Journal:  Turk J Urol       Date:  2018-03-01

6.  Hematoma in Retzius' space following US-guided prostate biopsy: evidence of the diagnostic accuracy using transrectal end-fire probe in the anterior prostate gland.

Authors:  Lucio Dell'atti
Journal:  J Ultrasound       Date:  2014-01-09

7.  Multiparametric magnetic resonance imaging (MRI) and subsequent MRI/ultrasonography fusion-guided biopsy increase the detection of anteriorly located prostate cancers.

Authors:  Dmitry Volkin; Baris Turkbey; Anthony N Hoang; Soroush Rais-Bahrami; Nitin Yerram; Annerleim Walton-Diaz; Jeffrey W Nix; Bradford J Wood; Peter L Choyke; Peter A Pinto
Journal:  BJU Int       Date:  2014-10-18       Impact factor: 5.588

Review 8.  Optimization of initial prostate biopsy in clinical practice: sampling, labeling and specimen processing.

Authors:  Marc A Bjurlin; H Ballentine Carter; Paul Schellhammer; Michael S Cookson; Leonard G Gomella; Dean Troyer; Thomas M Wheeler; Steven Schlossberg; David F Penson; Samir S Taneja
Journal:  J Urol       Date:  2013-02-26       Impact factor: 7.450

9.  Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion device.

Authors:  Geoffrey A Sonn; Shyam Natarajan; Daniel J A Margolis; Malu MacAiran; Patricia Lieu; Jiaoti Huang; Frederick J Dorey; Leonard S Marks
Journal:  J Urol       Date:  2012-11-14       Impact factor: 7.450

Review 10.  Screening and detection advances in magnetic resonance image-guided prostate biopsy.

Authors:  Samuel K Stephenson; Edward K Chang; Leonard S Marks
Journal:  Urol Clin North Am       Date:  2014-05       Impact factor: 2.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.